Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,054,924
+$23,360 QoQ
Shares Held
12,077
-1.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#782
of 2,602 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bell Asset Management Ltd holds $14,087,283 across 3 Diagnostics & Research names. TMO ranks #1 (43.0% of the industry book) .
All Filings in TMO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,054,924 | 12,077 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,031,564 | 12,271 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,046,430 | 8,709 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,621,159 | 7,466 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,949,180 | 9,740 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,603,795 | 9,252 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,655,940 | 10,872 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,785,712 | 10,970 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,349,194 | 15,098 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,838,460 | 15,207 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,093,485 | 15,248 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,717,573 | 15,247 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,250,043 | 11,979 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||